|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle
1 Department of Internal Medicine, Hypertension Division, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
Vasoconstrictor responses to sympathetic nerve stimulation and their sensitivity to metabolic modulation reportedly differ in fast-twitch and slow-twitch muscles, but the underlying mechanisms are not known. Both
1- and
2-adrenoceptors mediate these vascular responses in fast-twitch muscle, while their roles in slow-twitch muscle are less well defined. In this study, the phosphorylation of smooth muscle myosin regulatory light chain (smRLC) was measured as an index of vasoconstriction in slow-twitch soleus muscles and fast-twitch extensor digitorum longus (EDL) muscles isolated from C57BL/6J mice. In soleus muscles, incubation with phenylephrine (PE) or UK 14,304 to selectively activate
1- or
2-adrenoceptors resulted in concentration-dependent increases in smRLC phosphorylation. To evaluate metabolic modulation of these responses, vasodilator pathways previously implicated in such modulation in fast-twitch muscle were activated in soleus muscles by treatment with the nitric oxide (NO) donor nitroprusside or the ATP-sensitive potassium (KATP) channel opener cromakalim. Both drugs inhibited responses to UK 14,304, but not to PE. The effect of nitroprusside to antagonize UK 14,304 responses was prevented by inhibition of guanylyl cyclase or by blockade of KATP channels, but not by blockade of other potassium channels. Results were similar in EDL muscles. These data provide the first evidence for
2-adrenoceptor-mediated constriction in slow-twitch muscle, and show that it is sensitive to modulation by NO via a cGMP-dependent mechanism that requires KATP channel activation. Based on the similar findings in soleus and EDL muscles, fibre type does not appear to determine the innate vascular response to
1- or
2-adrenoceptor activation.
(Received 7 December 2004;
accepted after revision 23 December 2004;
first published online 23 December 2004)
Corresponding author G. D. Thomas: University of Texas Southwestern Medical Center, Hypertension Division, 5323 Harry Hines Blvd, Dallas, TX 75390-8586, USA. Email: gail.thomas{at}utsouthwestern.edu
This article has been cited by other articles:
![]() |
G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Joyner Too Much Is Not Enough: Hypertension and Sympathetic Vasoconstriction in Contracting Muscles Hypertension, October 1, 2006; 48(4): 560 - 561. [Full Text] [PDF] |
||||
![]() |
W. G. Schrage, B. W. Wilkins, V. L. Dean, J. P. Scott, N. K. Henry, M. E. Wylam, and M. J. Joyner Exercise hyperemia and vasoconstrictor responses in humans with cystic fibrosis J Appl Physiol, November 1, 2005; 99(5): 1866 - 1871. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |